In the last 12 months, insiders at 20/20 Biolabs, Inc. ($AIDX) filed 11 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
20/20 Biolabs, Inc. operates in the Services-testing laboratories industry (Industrial Applications and Services sector).
Most Active Insiders
- Rollins John Woodson (Director) — 4 transactions totaling $0
- Compton John G. (Director) — 2 transactions totaling $0
- Ross Michael A. (Director) — 2 transactions totaling $0
- COHEN RICHARD M (Director) — 2 transactions totaling $0
- Cohen Jonathan M (Chief Executive Officer) — 1 transaction totaling $0
View all SEC Filings for 20/20 Biolabs, Inc. (AIDX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Cohen Jonathan M | Chief Executive Officer | A | Stock Option | 352936 | $0.00 | 352,936.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2026 | Rollins John Woodson | Director | C | Common Stock | 6135 | $0.00 | 30,275.0000 | 0 | 25.41% | 0.00% |
| Feb. 19, 2026 | Rollins John Woodson | Director | C | Series A Preferred Stock | 13029 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2026 | Rollins John Woodson | Director | C | Series A-2 Preferred Stock | 6135 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2026 | Ross Michael A. | Director | C | Common Stock | 31 | $0.00 | 31.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2026 | Rollins John Woodson | Director | C | Common Stock | 13029 | $0.00 | 24,140.0000 | 0 | 117.26% | 0.00% |
| Feb. 19, 2026 | Compton John G. | Director | C | Common Stock | 7669 | $0.00 | 14,335.0000 | 0 | 115.05% | 0.00% |
| Feb. 19, 2026 | Compton John G. | Director | C | Series A-2 Preferred Stock | 7669 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2026 | COHEN RICHARD M | Director | C | Common Stock | 7700 | $0.00 | 7,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2026 | COHEN RICHARD M | Director | C | Series A-2 Preferred Stock | 7700 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2026 | Ross Michael A. | Director | C | Series A-2 Preferred Stock | 31 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |